Mindst 64% af patienterne blev betegnet som ” responspatienter ”, da deres HbA1c- niveau enten faldt med mindst 0, 6% fra baseline- værdien i løbet af undersøgelserne eller var på 6, 1% eller mindre ved undersøgelsernes afslutning.
At least 64% of the patients treated were classified as ‘ responders’, since their HbA1c levels either fell by at least 0.6% from the baseline value over the course of the studies, or their HbA1c levels were 6.1% or less at the end of the studies.